🇺🇸 FDA
Pipeline program

Extended treatment

CA118035

Phase 3 small_molecule completed

Quick answer

Extended treatment for Nicotine Dependence is a Phase 3 program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Nicotine Dependence
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials